Joint Prague-Weizmann Summer School on Drug Discovery
31 August — 4 September 2020
Weizmann Institute of Science, Rehovot, Israel
The seventh iteration of the Prague Summer School on Advances in Drug Discovery, and the third year in a row it is held jointly with the Weizmann Institute of Science. The school is co-organized by the IOCB Prague and the University of Chemistry and Technology, Prague.
The school is intended mainly for PhD students and postdocs. Expert speakers from academia as well as major international pharma and biotech companies will cover among others:
- Target discovery and validation
- Medicinal chemistry
- Structure and In silico based drug design
- Fragment based drug discovery
- Covalent drug discovery
- Principles and examples of commercial drug development cycle
- Additional topics such as: DNA encoded libraries, Immunoncology and Proteomics based diagnostics
Speakers
- Daniela Angst, Novartis
- Yimon Aye, EPFL
- Ingo Hartung, Merck
- Michal Hocek, IOCB Prague
- Torsten Hoffman, Taros
- Kilian Huber, Oxford
- Jiří Jiráček, IOCB Prague
- Martin Kuchař, UCT
- Pavel Martásek, Biocev
- Yifat Merbl, Weizmann Institute of Science
- Dario Neri, ETH
- Herman Overkeeft, Leiden University
- Vineet Pande, J&J
- Miloslav Polášek, IOCB Prague
- Michaela Rumlová, UCT
- Yardena Samuels, Weizmann Institute of Science
- Moran Shalev-Benami, Weizmann Institute of Science
- Andy Wilson, Leeds University
- Gail Wrigley, AstraZeneca
- György Miklós Keserű, Hungarian Academy of Sciences